CME Information

Title & Description:

ASNC2022 OnDemand is a digital library of 55.25 hours of educational content presented from the ASNC2022 27th Annual Scientific Meeting hosted September 8-25, 2022.

 

ASNC2022 OnDemand features:

  • Online video access to presenters’ slides with synchronized audio
  • Searchable slide content
  • Ability to earn up to 55.25 AMA PRA Category 1 Credits™
  • PC and MAC compatible
  • Mobile version for most smartphone and tablet devices
  • MP3 downloads

 

Overall Purpose: This activity will increase learners’ competence in solving technical and clinical issues when treating patients with CVD.  Sessions present different approaches to cardiac disease management to how to best improve patient outcomes. These sessions address topics in appropriate use criteria, SPECT best practices, PET best practices, new and emergent cardiac imaging procedures, lab performance and procedures, radiation safety, reporting, and lab performance and the application of appropriate guidelines-based treatments.

 

Statement of Need

In order to maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2022 On Demand is an educational activity designed to help imaging professionals on how to best improve outcomes for their patients with CVD.

Target Audience

This course is intended for cardiologists, radiologists, nuclear medicine specialists, practice administrators, nuclear technologists, nurses and other health care professionals with an interest in the field of nuclear cardiology.

Learning Objectives:

At the end of this activity, participants will:

  • Demonstrate improved skills in image interpretation and reporting
  • Learn how to recognize and minimize technical problems and artifacts that may be associated with cardiac imaging
  • Learn the appropriate use of cardiac imaging techniques based on current guidelines
  • Evaluate new imaging technologies, software, and stress techniques
  • Understand the role of nuclear and cardiac CT imaging in overall patient care
  • Learn the importance of balancing radiation exposure with image quality
  • Describe future directions in cardiac PET, CT, and SPECT/CT in order to anticipate training and equipment needs
  • Understand the clinical implication of CT coronary angiography cases and recognize its value and limitations in clinical cardiology

Important Dates

Date of Release: October 5, 2022

Date of CME Expiration: September 26, 2023

Date of Termination: September 26, 2024

Please note that credit will only be available through the term of approval noted above. 

Accreditation and Continuing Education Credit

Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this internet enduring activity for a maximum of 55.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

As an Accreditation Council for Continuing Medical Education (ACCME) accredited continuing medical education (CME) provider, the American Society of Nuclear Cardiology adheres to the ACCME’s Standards for Commercial Support.  In compliance with these standards, it is ASNCs policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through disclosure of relevant financial relationships with commercial companies and resolution of conflicts of interest.  The financial interest or relationships requiring disclosure are outlined in ASNC’s Conflict of Interest Policy. All planners, reviewers, moderators, presenters involved in this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and managed or mitigated all identified conflicts of interests.

To receive CME credit for this product, you must:

  1. Purchase the product.
  2. Read the CME Information available when you first enter the player or by clicking the CME Info link in the top right corner.
  3. View the session(s) of your choosing.
  4. View a CME eligible session and select the “Take Test” button in blue beneath the session to evaluate and claim credit.
  5. You may generate and print your CME certificate at any time by selecting the middle button in the upper right of your OnDemand.

Planners

Program Chairs

Karthikeyan Ananthasubramaniam, MD, FASNC, Chair

Rami Doukky, MD, FASNC, Vice-chair

 

 

 

 

Program Committee

Brian Abbott, MD, MASNC

Niti Aggarwal, MD, FASNC

Mouaz Al-Mallah, MD, MSc, FASNC

Parthiban Arumugam, MB BS

Renee Bullock-Palmer, MD, FASNC

Manuel Cerqueira, MD, MASNC

Panithaya Chareonthaitawee, MD

Paul Cremer, MD

Robert deKemp, PhD, FASNC

Sharmila Dorbala, MD, MPH, MASNC

Timothy Dunn, CNMT

Andrew Einstein, MD, PhD, FASNC

Cesia Gallegos, MD

Wael Jaber, MD

Diwakar Jain, MD, MASNC

Frederike Keatinge, MD

Madison Kocher, MD

Haresh Majmundar, CNMT, RT(N)

Saurabh Malhotra, MD, MPH, FASNC

Heisha McCall, PhD

Edward Miller, MD, PhD, FASNC

Venkatesh Murthy, MD, PhD, FASNC

Krishna Patel, MD

Donna Polk, MD, MPH, FASNC

Terrence Ruddy, MD, MASNC

Raymond Russell, MD, PhD, MASNC

Mehran Sadeghi, MD

Ibrahim Saeed, MD

Rupa Sanghani, MD, FASNC

Thomas Schindler, MD

Ronald Schwartz, MD, MS, MASNC

Nishant Shah, MD, MPH, FASNC

Albert Sinusas, MD, FASNC

Piotr Slomka, PhD, FASNC

Prem Soman, MD, PhD, MASNC

Vikas Veeranna, MD

 

 

Disclosure Information Report

American Society of Nuclear Cardiology

 

Faculty/Planner Disclosures

 

The following individuals have stated that they have no financial relationships with any ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or own patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:

Bryan Abadie, MD

Brian G. Abbott, MD, MASNC

Shady Abohashem, MD

Wael AlJaroudi, MD, FASNC

Erin Armenia, MD

Benjamin Auer, PhD

Sabha Bhatti, MD, FASNC

George A. Beller, MD, MASNC

Stephen A. Bloom, MD, FASNC

Renee Bullock-Palmer, MD, FASNC

Dennis A. Calnon, MD, MASNC

Paul Cremer, MD

Simhan Danthi, , PhD

  1. Gordon DePuey, MD, MASNC

Sanjay Divakaran, MD

Tifany Dong, MD

Eoin Donnellan, MB, BCh

Rami Doukky, MD, MBA, FASNC

Timothy L. Dunn, CNMT

Jane Dunne

Monica Embry-Dierson, CNMT

Mary Beth Farrell, CNMT, NCT

Mario Garcia, MD

Akshay Goel, MD

Javier Gomez Valencia, MD

Alan Goldberg, MD

Javier Gomez Valencia, MD

John P. Greenwood, MD

Robert C. Hendel, MD, MASNC

Milena J. Henzlova, MD, PhD, MASNC

Stephen Horgan, MD

Erika Hutt, MD

Ami E. Iskandrian, MD, MASNC

Anas Jawaid, MD

Abhinav Jha, PhD

Lynne L. Johnson, MD

Hayan Jouni, MD

Raghav Julakanti, MD

Friederike Keating, MD

Shaden Khalaf, MD

Madison Kocher, MD

Bruno Lima, MD, PhD

Maria L. Mackin, MS, CNMT, RT(N)

Chaitanya Madamanchi, MD

Samia Massalha, MD, FASNC

Keisha McCall, PhD

Matthew J. Memmott, MSc

Edward J. Miller, MD, PhD, FASNC

Faisal Nabi, MD

Diana Paez, MD

Shivda Pandey, MD

Gary Parizher, MD

Mi-Ae Park, PhD

Krishna Patel, MD

Donna M. Polk, MD, MPH, FASNC

Prajwal Reddy, MD

Dawn Roberts

Jeffrey A. Rosenblatt, MD, FASNC

Jean Michael Saad, MD

Thomas H. Schindler, MD, PhD

Eric J. Schockling, CNMT

Ronald G. Schwartz, MD MS, MASNC

Maria Sciammarella, MD

Ravi Shah, MD

Mrinali Shetty, MD

John Stendahl, MD, PhD

Amanda Swift, CNMT

Suman Tandon, MD

Viviany R. Taqueti, MD, FASNC

Samee Taywade, MB BS

Amr Telmasani, MB BS

Randall C. Thompson, MD, FASNC

Vikas Veeranna, MD

Brittany Weber, MD, PHD

Christiane Wiefels, MD, MSc

Kim A. Williams Sr., MD, MASNC

David E. Winchester, MD, FASNC

Kathleen Young, MD

George Zubal, PhD

 

 

 

The following individuals have provided financial relationships with ineligible company whose primary business is producing, marketing, selling, re-selling, or distributing products used by or own patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:

Niti R. Aggarwal, MD, FASNC – Speaker/Honoraria: Elsevier

Cigdem Akincioglu, MD – Consultant and Speaker/Honoraria: Pfizer Canada

Mouaz H. Al-Mallah, MD, MSc, FASNC – Consultant: Phillips, Jubilant, Pfizer; Research Grant: Siemens

Karthikeyan Ananthasubramaniam, MD, FASNC – Research Grant: Astellas, Lantheus, Alnylam, BMS; Speaker/Honoraria: BMS (non-branded)

Ian S. Armstrong, PhD – Speaker/Honoraria: Siemens; Other: Departmental collaboration – Siemens

Parthiban Arumugam, MBBS – Speaker/Honoraria: IBA

Mir Basir, DO – Consultant: Abbott Vascular, Abiomed, Boston Scientific, Cardiovascular Systems, Zoll; Research Grant: Abiomed, Zoll; Speaker/Honoraria: Abiomed, Boston Scientific, Cardiovascular Systems, Zoll

Timothy M. Bateman, MD, MASNC – Consultant: GEHC; Research Grant: Bracco, GEHC, Spectrum Dynamics; Owner/Interest: SPECT and PET software products

Rob S.B Beanlands, MD, MASNC – Consultant: GEHC, Jubilant DRAXImage, Lantheus; Research Grant: GEHC, Siemens; Advisory Board: Pfizer, Abbott; Speaker/Honoraria: Curium, GEHC, Pfizer

Frank Bengel, MD – Research Grant: GEHC, Jubilant DRAXImage, Lantheus

Daniel S. Berman, MD, MASNC – Consultant: GEHC; Royalties: Cedars Sinai (software)

Ron Blankstein, MD, FASNC – Consultant: Amgen, Novartis, Silence Therapeutics, Caristo Inc., Star Therapeutics, Roivant Sciences; Research Grant: Amgen, Novartis

Sabahat Bokhari, MD – Advisory Board: Pfizer, Alnylam, Biobridge

Jamieson M. Bourque, MD, FASNC – Consultant: Pfizer, GEHC

Paco Bravo, MD – CARDIAG Steering Committee: Life Molecular Imaging; Research Grant: Lantheus, Pfizer, Novartis

James A. Case, PhD – Research Grant: GEHC, Bracco Diagnostics, DRAXImage; Owner/Interest: CVIT

Manuel D. Cerqueira, MD, MASNC – Consultant: GEHC; Speaker/Honoraria: Astellas

Panithaya Chareonthaitawee, MD – Consultant: BioClinica; Royalties: UpToDate

Leslie Cho, MD – Consultant: AstraZeneca

Andrew Choi, MD – Consultant: Siemens Healthineers; Other: Cleerly (stock)

Benjamin Chow, MD, FASNC – Research Grant: TD Bank, AusculSciences, Artyra, Siemens; Owner/Interest: Artrya (stock options)

Sarah Cuddy, MB ChB – Research Grant: Pfizer; Speaker/Honoraria: BridgeBio, Ionis, Lynx Group

Robert A. deKemp, PhD, FASNC – Consultant: Jubilant DRAXImage; Research Grant: Jubilant DRAXImage, Lantheus, Siemens; Royalties: INVIA, Jubilant DRAXImage

Marcelo Di Carli, MD, MASNC – Research Grant: Gilead Sciences, Spectrum Dynamics

Vasken Dilsizian, MD, MASNC – Research Grant: GEHC

Sharmila Dorbala, MD, MPH, MASNC – Research Grant: Pfizer, GEHC, Attralus; Advisory Board: Pfizer, GEHC, Janssen, Eidos; Speaker/Honoraria: Ionetix

  1. Lane Duvall, MD, FASNC – Consultant: GEHC; Research Grant: GEHC

Andrew J. Einstein, MD, PhD, FASNC – Consultant: W.L. Gore & Assoc.; Research Grant: W.L. Gore & Assoc., GEHC (grants from columbia)

John Friedman, MD – Royalties: Cedars-Sinai software

Brian Ghoshharja, MD – Consultant & Gtants: Siemens (to institution); Consultant: Philips

Sherita Golden, MD, MHS – Consultant: Medtronic, Abbott; Advisory Board: Medtronic, Abbott

Robert J. Gropler, MD, MASNC – Research Grant: GEHC

Gabriel B. Grossman, MD, PhD, FASNC – Consultant: Pfizer, Siemens; Speaker/Honoraria: Siemens

Fadi G. Hage, MD, MASNC – Other: GEHC (Site for clinical trial)

Saen Hayes, MD – Royalties: Cedars-Sinai software

Gary V. Heller, MD, PhD, MASNC – Consultant: MIS, Digirad; Advisory Board: GEHC

Fabien Hyafil, MD, PhD

Consultant: Naogen Pharma, Bracco Imaging; Speaker: Pfizer, GE Healthcare, Bracco Imaging; Advisory Board: Naogen Pharma, Bracco Imaging; Stock options: Naogen Pharma

Mark C. Hyun, CNMT, NCT, RT(N)(R), FASNC – Consultant: Astellas; Speaker/Honoraria: Astellas

Wael A. Jaber, MD – Consultant: Pfizer; Other: Edwards Life Sciences, Boston Scientific (Instritutional Corelab: no personal payment)

Diwakar Jain, MD, MASNC – Consultant: Astellas; Research Grant: CSL Behring (investigator); Speaker/Honoraria: Astellas, Pfizer; Other: GEHC (member of DSMB multicenter trial

Scott Jerome, DO, FASNC – Advisory Board (health information technology group): Pfizer

Nils Johnson, MD Consultant (Institutional): Boston Scientific, Abbott Vascular; Speaker (institutional) Boston Scientific, Abbott Vascular; Other (institutional support): DEFINE FLOW, Impella study, PPG Registrty, HeartSee (license)

Joel Karp, PhD – Research Grant: Siemens, Philips (PI agreement with U.Penn)

Jamshid Maddahi, MD, FASNC – Consultant: GEHC; Research Grant: GEHC

Haresh Majmundar, CNMT, RT(N) – Consultant: GLG Corp.

Saurabh Malhotra, MD, MPH, FASNC – Consultant: Astellas, Eidos; Speaker/Honoraria: Astellas, Pfizer

Ahmad Masri, MD – Consultant: BMS, Cytokinetics, Eidos, Tenaya, Attralus, Ionis; Research Grant: Pfizer, Ultronics, Ionis – Speaker/Honoraria: Alnylam, Pfizer

Venkatesh Murthy, MD, PhD, FASNC – Consultant: INVIA, Ionetix, Siemens; Research Support: NHLBI, NIA, NCI, INVIA, Siemens; Stock options: General Electric, Cardinal Health, Ionetix

Michael T. Osborne, MD – Consultant: WCG Intrinsic Imaging; Research Grant: NIH

Amit R. Patel, MD – Research Grant: Circle CVU, Siemens Healthineers, General Electric

Lawrence M. Phillips, MD, FASNC – Consultant: NovoNordisk: research study clinical ev adjudication committee

Terrence D. Ruddy, MD, MASNC – Research Grant: GEHC, Advanced Accelerator Applications; Speaker/Honoraria: Ion Beam Applications

Raymond R. Russell III, MD, PhD, MASNC – Speaker/Honoraria: Alnylam; Royalties: Dicerna Pharmaceuticals (stock options); Other: Restorbio, Disernca Pharma (spouse employer)

Mehran Sadeghi, MD  – Consultant: Bracco; Resarch Materials” Alexion Pharmaceuticals; Other: Boehringer Ingelheim (spouse employment)

Rupa Mehta Sanghani, MD, FASNC – Advisory Board: FDA Medical Imaging; Other: Elsevier (writer)

Nishant Shah, MD, MPH, FASNC – Royalties: GEHC (stock)

Leslee J. Shaw, PhD, MASNC – Advisory Board: Covanos, Elucid Imaging; Speaker/Honoraria: Amgen, Roche Diagnostics, K2P

Chetan Shenoy, MD – Consultant: Medtronic

Vasvi Singh, MD – Research Grant: Pfizer

Albert J. Sinusas, MD, FASNC – Consultant: MicroVide, LLC (limited partner); Research Grant: Siemens, Jubilant

Piotr J. Slomka, PhD, FASNC – Research Grant: Siemens; Speaker/Honoraria: IBA; Royalties: Cedars_Sinai (software)

Prem Soman, MD, PhD, MASNC – Consultant: Alnylam, Spectrum Dynamics, Eidos, Pfizer; Research Grant: Pfizer, Astellas

Brett W. Sperry, MD – Consultant: Pfizer, BridgeBio, Alnylam; Speaker/Honoraria: Pfizer

Eric Velazquez, MD – Consultant: Novartis, Abiomed, Baim Inst. For Medical Research; Advisory Board: Novartis, Abiomed, Baim Inst. For Medical Research, Amgen

Jaime Warren, EdD,MBA, CNMT, NCT – Owner/Interest: MeAxiom (employee)

Richard Weinberg, MD, PhD, FASNC – Consultant: Ionetix

  1. Glenn Wells, PhD – Research Grant: Pfizer, GEHC

Jessica Williams, MS, RT(N), CNMT – Employee: Blue Earth Diagnostics, Ltd.

David G. Wolinsky, MD, MASNC – Consultant: Astellas, Pfizer, Alnylam, BridgeBio, Ionis – Advisory Board: Pfizer, Alnylam; Speaker/Honoraria: Astellas

 

Off Label-Use

Presentations may include discussion of drugs or devices, or uses of drugs or devices, which have not been approved by the U.S. Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented. Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.

 

 

 

Medium or Combination of Medium Used: 

ASNC2022 OnDemand is available online on most mobile devices, including smartphones and tablets.   

Hardware/Software Requirements: For the most current list of system requirements, please visit http://asnc.ondemand.org/.

Provider Contact Information:

For ASNC2022 OnDemand Customer Support:

[email protected] or (818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only)

ASNC Contact Information:

American Society of Nuclear Cardiology
9302 Lee Highway, Suite 1210
Fairfax, Virginia 22031
Phone: 703-459-2555
[email protected]

 

Privacy Policy

This website is provided by Wolters Kluwer.  By using this website, you consent to the use of your Personal Data as described in this Privacy Policy (‘Policy’). The Privacy Policy can be found at www.audio-digest.org/privacy and may be updated at any time.

ASNC2021: 26th Annual Session Meeting on Demand 

 American Society of Nuclear Cardiology 

Title & Description: 

ASNC2021 OnDemand is a digital library of 54.5 hours of educational content presented from the live virtual ASNC2021 26th Annual Scientific Meeting hosted September 21-October 13, 2021. 

ASNC2021 OnDemand features: 

  • Online access to presenters’ slides with synchronized audio 
  • Searchable slide content 
  • Ability to earn up to 54.5 AMA PRA Category 1 Credits™ 
  • PC and MAC compatible 
  • Mobile version for most smartphone and tablet devices 
  • MP3 downloads

Overall Purpose: This activity will increase learners’ competence in solving technical and clinical issues when treating patients with CVD.  Sessions present different approaches to cardiac disease management to how to best improve patient outcomes. These sessions address topics in appropriate use criteria, SPECT best practices, PET best practices, new and emergent cardiac imaging procedures, lab performance and procedures, radiation safety, reporting, and lab performance and the application of appropriate guidelines-based treatments. 

Statement of Need  

In order to maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2021 On Demand is an educational activity designed to help imaging professionals on how to best improve outcomes for their patients with CVD. 

Target Audience 

This course is intended for cardiologists, radiologists, nuclear medicine specialists, practice administrators, nuclear technologists, nurses and other health care professionals with an interest in the field of nuclear cardiology. 

Learning Objectives: 

At the end of this activity, participants will: 

  • Demonstrate improved skills in image interpretation and reporting 
  • Learn how to recognize and minimize technical problems and artifacts that may be associated with cardiac imaging 
  • Learn the appropriate use of cardiac imaging techniques based on current guidelines 
  • Evaluate new imaging technologies, software, and stress techniques 
  • Understand the role of nuclear and cardiac CT imaging in overall patient care 
  • Learn the importance of balancing radiation exposure with image quality 
  • Describe future directions in cardiac PET, CT, and SPECT/CT in order to anticipate training and equipment needs 
  • Understand the clinical implication of CT coronary angiography cases and recognize its value and limitations in clinical cardiology

Important Dates 

Date of Release: October 18, 2021 

Date of CME Expiration: October 15, 2022 

Date of Termination: October 16, 2023 

Please note that credit will only be available through the term of approval noted above.  

Accreditation and Continuing Education Credit 

Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this internet enduring activity for a maximum of 54.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Disclosure Policy 

As an Accreditation Council for Continuing Medical Education (ACCME) accredited continuing medical education (CME) provider, the American Society of Nuclear Cardiology adheres to the ACCME’s Standards for Commercial Support.  In compliance with these standards, it is ASNCs policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through disclosure of relevant financial relationships with commercial companies and resolution of conflicts of interest.  The financial interest or relationships requiring disclosure are outlined in ASNC’s Conflict of Interest Policy. All planners, reviewers, moderators, presenters involved in this activity were required to disclose any relevant financial relationships. 

The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interests through a peer review process. 

Planners 

Program Chairs 

Piotr Slomka, PhD, FASNC, Chair 

Karthikeyan Ananthasubramaniam, MD, FASNC, Vice-chair  

Program Committee 

Niti Aggarwal, MD, FASNC 

Mouaz Al-Mallah, MD, MSc, FASNC 

Renee Bullock-Palmer, MD, FASNC 

Dennis Calnon, MD, MASNC 

Panithaya Chareonthaitawee, MD 

Benjamin Chow, MD, FASNC 

Sarah Cuddy, MB ChB 

Robert deKemp, PhD, FASNC 

Sharmila Dorbala, MD, MPH, MASNC

Lane Duvall, MD, FASNC

Cesia Gallegos, MD 

Fadi Hage, MD, MASNC 

Gary Heller, MD, PhD, MASNC 

Robert Hendel, MD, MASNC 

Chi Liu, PhD 

Maria Mackin, CNMT, RT, RT(N) 

Samia Massalha, MD 

Robert Miller, MD 

Venkatesh Murthy, MD, PhD, FASNC 

Rene Packard, MD, PhD 

Shivda Pandey, MD, FASNC 

Krishna Patel, MD 

Amalia Peix Gonzales, MD, PhD 

Lawrence Phillips, MD, FASNC  

Mehran Sadeghi, MD 

Ibrahim Saeed, MD 

Rupa Sanghani, MD, FASNC 

Nishant Shah, MD, MPH, FASNC 

Mrinali Shetty, MD 

Albert Sinusas, MD, FASNC 

Prem Soman, MD, PhD, MASNC 

Brett Sperry, MD 

Sina Tavakoli, MD, PhD 

Javier Valencia Gomez, MD 

Jaime Warren, CNMT, MBA 

Kim Williams, MD, MASNC 

Full list of faculty disclosures can be accessed here. Also, disclosures appear in individual sessions. 

To receive CME credit for this product, you must: 

  1. Purchase the product. 
  2. Read the CME Information available when you first enter the player or by clicking the CME Info link in the top right corner. 
  3. View the session(s) of your choosing. 
  4. Evaluate each session after viewing if you intend to claim credit.
  5. Generate and print your CME certificate. 

Off Label-Use 

Presentations may include discussion of drugs or devices, or uses of drugs or devices, which have not been approved by the U.S. Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented. Presenters are required to disclose to the learners, if there is any off-label usage within the presentation. 

Medium or Combination of Medium Used:   

ASNC2021 OnDemand is available online on most mobile devices, including smartphones and tablets. 

Hardware/Software Requirements: For the most current list of system requirements, please visit http://asnc.ondemand.org/. 

Provider Contact Information: 

For ASNC2021 OnDemand Customer Support: 

[email protected] or (818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only) 

ASNC Contact Information: 

American Society of Nuclear Cardiology 
9302 Lee Highway, Suite 1210 
Fairfax, Virginia 22031 
Phone: 703-459-2555 
[email protected] 

Privacy Policy 

This website is provided by Wolters Kluwer.  By using this website, you consent to the use of your Personal Data as described in this Privacy Policy (‘Policy’). The Privacy Policy can be found at www.audio-digest.org/privacy and may be updated at any time. 

Title & Description:

ASNC Nuclear Cardiology Board Exam Preparation Course OnDemand 2022 is a digital library of 31.25 hours of educational content presented at the 2022 September 17–18 Nuclear Cardiology Virtual Board Examination Prep Meeting, in addition to supplementary content from the ASNC2022 session, Nuclear Cardiology Foundations and Application: A Case-based Morning with the Board Prep Faculty.

 

Nuclear Cardiology Board Prep OnDemand features:

  • Online access to presenters’ slides with synchronized audio
  • Searchable slide content
  • Ability to earn up to 31.25 AMA PRA Category 1 Credits™and 31.25 Maintenance of Certification (MOC) points
  • MP3 downloads (‘podcasts’)
  • PDF downloads of slide presentations
  • PC and MAC compatible
  • Mobile version for most smartphone and tablet devices

 

Overall Goal

The overall goal of this activity is to increase physician competence in nuclear cardiology by providing a comprehensive review, including the most up-to-date information, developments, treatment protocols, methodology, and best test for the right patient at the right time to optimize patient outcomes in their nuclear cardiology practice.

 

Needs Statement

Radionuclide-based cardiac imaging studies, including myocardial perfusion imaging (MPI), play an important role in the diagnosis and management of patients with suspected or known heart disease. Today more than 5000 laboratories are performing an estimated 8 million myocardial perfusion studies, of which 58% use pharmacological stress agents, either alone or with exercise.* A large body of scientific evidence exists on the clinical value of MPI, based on studies performed on many thousands of patients. These studies are highly sensitive and specific for the diagnosis, prognosis, and treatment response of coronary artery disease, as well as for selection of patients who may benefit from other types of intervention, including revascularization and device therapy. The value and justification of MPI for risk assessment is based on large observational outcome studies. As a result of the recognized clinical value and cost effectiveness of these studies, they have been incorporated into many ACC/American Heart Association (AHA)/ASNC clinical management guidelines.

 

Nuclear cardiology is an evolving field with continuing advances in software, instrumentation, and radiopharmaceuticals to provide high quality, clinically relevant information for patient care. These advances require those involved in providing nuclear cardiology studies to be updated continuously, to ensure the procedures are used appropriately and safely, and to assure recent clinical and technological advances are incorporated in a timely manner to continually improve the image quality and interpretation to provide the best clinical care. 

*Dicardiology.com. IMV market report. Posted December 26, 2013.

 

 

Target Audience

This course is designed for cardiologists, nuclear medicine physicians, and radiologists preparing for the certification or recertification exam in nuclear cardiology.

 

 

Learning Objectives

The primary objectives of the course are to enable participants to achieve the following:

  1. Apply nuclear cardiovascular imaging physics and instrumentation
  2. Explain image acquisition and processing considerations and identify associated artifacts
  3. Discuss the production and management of radionuclides and radiopharmaceuticals
  4. Incorporate patient-centered imaging principles and appropriate use considerations in nuclear cardiology and stress procedure selection
  5. Incorporate risk stratification into selection and application of nuclear cardiology studies
  6. Integrate radiation safety standards into professional nuclear cardiology practice
  7. Apply nuclear imaging tools in assessment of myocardial viability and cardiac amyloidosis
  8. Understand the basics of positron emission tomography (PET) imaging for myocardial perfusion and metabolic viability and sarcoidosis assessment
  9. Interpret SPECT and PET perfusion and metabolic images and ventricular function imaging
  10. Utilize myocardial perfusion imaging in the assessment, diagnosis, and response to therapy in patients with known or suspected coronary artery disease and special populations
  11. Appropriately identify non-cardiac findings on SPECT and PET-CT cardiovascular imaging studies
  12. Integrate nuclear cardiology into the multimodality imaging evaluation of cardiovascular disease

 

 

Important Dates:

Date of Release:                                          September 19, 2022

Date of CME Expiration:                            September 18, 2023

Date of Activity Expiration:                        September 18, 2024

 

Please note that credit will only be available through the term of approval noted above. 

 

Accreditation Statement
Continuing Medical Education Credit
The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Designation Statement
The American Society of Nuclear Cardiology designates this enduring material for a maximum of 31.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Requirements for successful completion and awarding of credit are as follows: participation in sessions offering credit in their entirety and successful completion of the post test and evaluation tool.  

 

Maintenance of Certification
Successful completion of this CME activity, which includes participation in the CME post-test and evaluation component, enables the participant to earn up to 31.25 medical knowledge Maintenance of Certification (MOC) points in the American Board of Internal Medicine (ABIM) MOC program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

 

To receive MOC points for participating in the Board Prep Course, you must be a diplomate of the American Board of Internal Medicine, and you must have an ABIM account. If you have not yet established an online account, you will need to visit http://www.abim.org, or contact ABIM by phone:
1-800-441-ABIM; Mon–Fri 8:30 am–8:00 pm ET, Sat 9:00 am–12:00 pm ET.

 

Please note, upon satisfactory completion of your Board Prep Course, passing the CME post-test, and completing the evaluation form, you will be prompted to enter your ABIM ID and DOB so your MOC points can be transferred to the ABIM. Please note this data will transfer at the end of every month into your ABIM record. ABIM will not accept MOC points for this internet live activity after September 18, 2023.

 

*Please Note: If you already claimed credit for attending the virtual live Nuclear Cardiology Board Exam Prep meeting, you may not claim credit for watching the same sessions on Nuclear Cardiology Board Prep OnDemand. 

 

While offering the CME credits noted above, this program is not intended to provide extensive training or certification in the field.

 

Program Chairs & Faculty

 

Program Chair

Jamieson Bourque, MD, MHS, FASNC

University of Virginia Health System

Charlottesville, VA

 

Program Co-Chair
Karthikeyan Ananthasubramaniam, MD, FASNC

Henry Ford West Bloomfield Hospital

West Bloomfield, MI

 

James A. Case, PhD, MASNC

Cardiovascular Imaging Technologies, LLC

Kansas City, MO

 

Panithaya Chareonthaitawee, MD, FACC, FAHA

Mayo Clinic College of Medicine

Rochester, MN

 

  1. David Cooke, MSEE

Emory University School of Medicine

Atlanta, GA

 

  1. Gordon DePuey, MD, MASNC

Professor Emeritus of Radiology

Columbia University College of Physicians and Surgeons

Professorial Lecturer

Icahn School of Medicine

New York, NY

 

Marcelo F. Di Carli, MD, MASNC

Brigham and Women’s Hospital

Boston, MA

 

Nick Dorrell, MS, CHP

University of Virginia Health System

Charlottesville, VA

 

Wendy Galbraith, PharmD, FAPhA, BCNP

The University of Oklahoma Health Sciences Center

Department of Pharmaceutical Sciences

Oklahoma City, OK

 

Robert C. Hendel, MD, MASNC

Tulane University School of Medicine

New Orleans, LA

 

Andrew C. Homb, MD

Mayo Clinic College of Medicine

Rochester, MN

 

Mark C. Hyun, CNMT, NCT, RS, RT(N,R,CT), FASNC

Cedars-Sinai Medical Center

Los Angeles, CA

 

Saurabh Malhotra, MD, MPH, FACC, FASNC

Cook County Health

Chicago, IL

 

Ronald G. Schwartz, MD, MS, FACC, FAHA, ABNM, MASNC

University of Rochester Medical Center

Rochester, NY

 

Prem Soman, MD, PhD, MASNC, FACC, FRCP (UK)

UPMC Division of Cardiology & UPMC Heart and Vascular Institute

Pittsburgh, PA

 

Michael Welling

Radiation Safety Officer

University of Virginia Health System

Charlottesville, VA

 

David E. Winchester, MD, MS, FACP, FACC, FASNC

Malcom Randall VAMC

University of Florida College of Medicine

Gainesville, FL

 

 

 

Planners

Jamieson Bourque, MD, MHS, FASNC (Course Director and Chair)

Karthikeyan Ananthasubramaniam, MD, FASNC (Co-Chair)

Victoria Anderson (ASNC staff)

Wendy Passerell (ASNC staff)

 

Reviewer

Firas J. Al Badarin, MD, FASNC (Education Committee Oversight)

John Stendahl, MD, PhD (Education Committee Oversight)

 

Disclosures

As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in its educational activities through the disclosure of all financial relationship with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers, and presenters involved with this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed these disclosures and mitigated or managed all identified conflicts of interest through a peer review process.

 

The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interest through a peer-review process.

The following planners, presenters, reviewers, and staff reported no financial relationships:

  1. Gordon DePuey, MD, MASNC

Nick Dorrell, MS, CHP

Wendy Galbraith, PharmD, FAPhA, BCNP

Andrew C. Homb, MD

Wendy Passerell (ASNC Staff)

Ronald G. Schwartz, MD, MS, FACC, FAHA, ABNM, MASNC

John Stendahl, MD, PhD

Michael Welling

David E. Winchester, MD, MS, FACP, FACC, FASNC

 

The following planners, presenters, reviewers, and staff reported financial relationships:

Firas J. Al Badarin, MD, FASNC: Advisory Board: Pfizer

Karthik Ananthasubramaniam, MD, FASNC: Research grants: Alnylam Pharmaceuticals, Astellas Pharma U.S. Inc., Bristol Myers Squibb, Lantheus Medical Imaging; Speakers Bureau: Bristol Myers Squibb.

Victoria Anderson (ASNC staff): Stock Interest, Abbott Labs and AbbVie Inc.

Jamieson Bourque, MD, MHS, FASNC: Consultant fee: Pfizer, GE Healthcare; Stock Interest: Locus Health

James A. Case, PhD, MASNC: Consultant fee: General Electric; Research grants: Bracco Diagnostics, General Electric, Jubilant DraxImage Inc., Siemens, Spectrum Dynamics; Intellectual Property Rights: Cardiovascular Imaging Technologies

Panithaya Chareonthaitawee, MD, FACC, FAHA: Consultant fee: Clario; Royalty: UpToDate®

  1. David Cooke, MSEE: Royalty: Syntermed, Inc. (Sales of Emory Cardiac Toolbox Software); Salaried Employee or Owner: Part-time employee of Syntermed, Inc.

Marcelo F. Di Carli, MD, MASNC: Institutional Research Grants: Gilead Sciences, Amgen; Funding from NHLBI

Robert Hendel, MD, MASNC: Speakers Bureau: Astellas Pharma

Mark C. Hyun, CNMT, NCT, RT(N)(R)(CT), FASNC: Consultant fee & Speakers Bureau: Astellas

Saurabh Malhotra, MD, MPH, FACC, FASNC: Advisory Board: Alnylam; Application Reviewer: Intersocietal Accreditation Commission (IAC); Research grants: Pfizer, Inc., Women’s Interagency HIV Study (WIHS); Speakers Bureau: Alnylam, Pfizer Inc.

Prem Soman, MD, PhD, MASNC, FACC, FRCP (UK): Consultant fees: Alnylam, Eidos, Spectrum Dynamics, Pfizer; Research Grant: Astellas Pharma, Pfizer

 

The American Society of Nuclear Cardiology reserves the right to modify faculty and topics as needed.

 

Off-Label Use

Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the U.S. Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented.  Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.

 

Acknowledgement of Commercial Support

This activity has not received any commercial support.

 

Method of Participation and CME Certificates

This product offers up to 31.25 AMA PRA Category 1 creditsTM and 31.25 ABIM Part II medical knowledge MOC points based on the number of hours you spend watching presentations and taking the post-test questions. You may re-enter the product as many times as you wish, but you can claim CME credit and MOC points only once. 

 

To receive CME credit for this product, you must:

  1. Purchase the product.
  2. Read the CME Information available when you first enter the player or by clicking the CME Info link in the top right corner.
  3. View the session(s) of your choosing.
  4. After you have completed viewing all sessions for which you intend to claim credit, click the Test link in the top right corner to begin the post-test, which is required to claim credit.
  5. Complete the post-test. You must score 75% to earn credit. You have unlimited attempts to retake the post-test. 
  6. Complete the meeting evaluation.
  7. Enter the number of credits you wish to claim (up to a maximum of 31.25 CME credits). Credits claimed should reflect the total number of hours you spent reviewing the CME information, watching sessions, and taking the post-test. (*If you already claimed credit for attending the virtual live Nuclear Cardiology Board Exam Prep Course, you may not claim credit for the same sessions on Nuclear Cardiology Board Prep OnDemand). 
  8. Generate and print your CME certificate.

 

Estimated time for completion of activity is 31.25 hours.

 

 

Learner’s Bill of Rights

The American Society of Nuclear Cardiology (ASNC) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill, or performance. As part of the ASNC’s duty to you as a learner, you have the right to expect that your continuing medical education experience with ASNC includes the following:

 

Content that:

  • promotes improvements or quality in healthcare;
  • is valid, reliable, and accurate;
  • offers balanced presentations that are free of commercial bias for or against a product or service;
  • is vetted through a process that resolves any conflicts of interests of planners, teachers, or authors; 
  • is driven and based on learning needs, not commercial interests;
  • addresses the stated objectives or purpose; and
  • is evaluated for its effectiveness in meeting the identified educational need.

 

A learning environment that:

  • supports the learners’ ability to meet their individual needs;
  • respects and attends to any special needs of the learners;
  • respects the diversity of groups of learners; and
  • is free of promotional, commercial, and/or sales activities.

 

Disclosure of:

  • relevant financial relationships planners, teachers, and authors have with commercial interests related to the content of the activity; and
  • commercial support (funding or in-kind resources) of the activity.

 

Participants are asked to evaluate the objectivity of each presentation and to identify any

perceived commercial bias.

 

Medium or Combination of Medium Used: 

Nuclear Cardiology Board Prep OnDemand is available online on most mobile devices, including smartphones and tablets.   

Hardware/Software Requirements: For the most current list of system requirements, please visit http://asnc.ondemand.org/.

 

Provider Contact Information:

For Nuclear Cardiology Board Prep OnDemand Customer Support:

[email protected] or (818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only)

 

ASNC Contact Information:

American Society of Nuclear Cardiology
9302 Lee Highway, Suite 1210
Fairfax, Virginia 22031
Phone: 703-459-2555
[email protected]

 

 

Privacy Policy

This website is provided by Learner’s Digest International LLC.  By using this website you consent to the use of your Personal Data (Defined Below) as described in this Privacy Policy (‘Policy’). The Privacy Policy can be found at www.audio-digest.org/privacy and may be updated at any time.

Nuclear Cardiology Board Prep OnDemand 2021 

September 18, 2021–September 19, 2023 

Title & Description: 

ASNC Nuclear Cardiology Board Exam Preparation Course OnDemand 2021 is a digital library of 26.5 hours of educational content presented at the 2021 September 18–19 Nuclear Cardiology Virtual Board Examination Prep Meeting. 

Nuclear Cardiology Board Prep OnDemand features: 

  • Online access to presenters’ slides with synchronized audio 
  • Searchable slide content 
  • Ability to earn up to 26.5 AMA PRA Category 1 Credits™ and 26.5 Maintenance of Certification (MOC) points 
  • PC and MAC compatible 
  • Mobile version for most smartphone and tablet devices 
  • MP3 downloads 

Overall Goal 

The overall goal of this activity is to increase physician competence in nuclear cardiology by providing a comprehensive review, including the most up-to-date information, developments, treatment protocols, methodology, and best test for the right patient at the right time to optimize patient outcomes in their nuclear cardiology practice. 

Needs Statement 

Radionuclide-based cardiac imaging studies, including myocardial perfusion imaging (MPI), play an important role in the diagnosis and management of patients with suspected or known heart disease. Today more than 5000 laboratories are performing an estimated 8 million myocardial perfusion studies, of which 58% use pharmacological stress agents, either alone or with exercise.* A large body of scientific evidence exists on the clinical value of MPI, based on studies performed on many thousands of patients. These studies are highly sensitive and specific for the diagnosis, prognosis, and treatment response of coronary artery disease, as well as for selection of patients who may benefit from other types of intervention, including revascularization and device therapy. The value and justification of MPI for risk assessment is based on large observational outcome studies. As a result of the recognized clinical value and cost effectiveness of these studies, they have been incorporated into many ACC/American Heart Association (AHA)/ASNC clinical management guidelines. 

Nuclear cardiology is an evolving field with continuing advances in software, instrumentation, and radiopharmaceuticals to provide high quality, clinically relevant information for patient care. These advances require those involved in providing nuclear cardiology studies to be updated continuously, to ensure the procedures are used appropriately and safely, and to assure recent clinical and technological advances are incorporated in a timely manner to continually improve the image quality and interpretation to provide the best clinical care.  

*Dicardiology.com. IMV market report. Posted December 26, 2013. 

Target Audience 

This course is designed for cardiologists, nuclear medicine physicians, and radiologists preparing for the certification or recertification exam in nuclear cardiology. 

Learning Objectives 

The primary objectives of the course are to enable participants to achieve the following: 

  1. Apply nuclear cardiovascular imaging physics and instrumentation 
  2. Explain image acquisition and processing considerations and identify associated artifacts 
  3. Discuss the production and management of radionuclides and radiopharmaceuticals 
  4. Incorporate patient-centered imaging principles and appropriate use considerations in nuclear cardiology and stress procedure selection 
  5. Incorporate risk stratification into selection and application of nuclear cardiology studies 
  6. Integrate radiation safety standards into professional nuclear cardiology practice 
  7. Apply nuclear imaging tools in assessment of myocardial viability and cardiac amyloidosis 
  8. Understand the basics of positron emission tomography (PET) imaging for myocardial perfusion and metabolic viability and sarcoidosis assessment 
  9. Interpret SPECT and PET perfusion and metabolic images and ventricular function imaging 
  10. Utilize myocardial perfusion imaging in the assessment, diagnosis, and response to therapy in patients with known or suspected coronary artery disease and special populations 
  11. Appropriately identify non-cardiac findings on SPECT and PET-CT cardiovascular imaging studies 
  12. Integrate nuclear cardiology into the multimodality imaging evaluation of cardiovascular disease 

Important Dates: 

Date of Release:                                          September 20, 2021 

Date of CME Expiration:                              September 19, 2022 

Date of Activity Expiration:                           September 19, 2023 

Please note that credit will only be available through the term of approval noted above.  

Accreditation Statement 
Continuing Medical Education Credit 
The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Designation Statement 
The American Society of Nuclear Cardiology designates this enduring material for a maximum of 26.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Requirements for successful completion and awarding of credit are as follows: participation in sessions offering credit in their entirety and successful completion of the post test and evaluation tool.   

Maintenance of Certification  
Successful completion of this CME activity, which includes participation in the CME post-test and evaluation component, enables the participant to earn up to 26.5 medical knowledge Maintenance of Certification (MOC) points in the American Board of Internal Medicine (ABIM) MOC program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

To receive MOC points for participating in the Board Prep Course, you must be a diplomate of the American Board of Internal Medicine, and you must have an ABIM account. If you have not yet established an online account, you will need to visit http://www.abim.org, or contact ABIM by phone: 
1-800-441-ABIM; Mon–Fri 8:30 am–8:00 pm ET, Sat 9:00 am–12:00 pm ET. 

Please note, upon satisfactory completion of your Board Prep Course, passing the CME post-test, and completing the evaluation form, you will be prompted to enter your ABIM ID and DOB so your MOC points can be transferred to the ABIM. Please note this data will transfer at the end of every month into your ABIM record. 

*Please Note: If you already claimed credit for attending the virtual live Nuclear Cardiology Board Exam Prep meeting, you may not claim credit for watching the same sessions on Nuclear Cardiology Board Prep OnDemand.   

While offering the CME credits noted above, this program is not intended to provide extensive training or certification in the field. 

Program Chairs & Faculty 

Program Chair 

Jamieson Bourque, MD, MHS, FASNC 

University of Virginia Health System 

Charlottesville, VA 

Program Co-Chair 
Karthikeyan Ananthasubramaniam, MD, FASNC 

Henry Ford West Bloomfield Hospital 

West Bloomfield, MI 

James A. Case, PhD, MASNC 

Cardiovascular Imaging Technologies, LLC 

Kansas City, MO 

Panithaya Chareonthaitawee, MD, FACC, FAHA 

Mayo Clinic College of Medicine 

Rochester, MN

David Cooke, MSEE

Emory University School of Medicine 

Atlanta, GA

Gordon DePuey, MD, MASNC

Mount Sinai Morningside Hospital 

New York, NY 

Bay Ridge Medical Imaging 

Brooklyn, NY 

Marcelo F. Di Carli, MD, MASNC 

Brigham and Women’s Hospital 

Boston, MA 

Wendy Galbraith, PharmD, FAPhA, BCNP 

The University of Oklahoma Health Sciences Center 

Department of Pharmaceutical Sciences 

Oklahoma City, OK 

Robert C. Hendel, MD, MASNC 

Tulane University School of Medicine 

New Orleans, LA 

Mark C. Hyun, CNMT, NCT, RS, RT(N,R,CT), FASNC 

Cedars-Sinai Medical Center 

Los Angeles, CA 

Saurabh Malhotra, MD, MPH, FACC, FASNC 

Cook County Health 

Chicago, IL 

Ronald G. Schwartz, MD, MS, FACC, FAHA, ABNM, MASNC 

University of Rochester Medical Center 

Rochester, NY 

Prem Soman, MD, PhD, MASNC, FACC, FRCP (UK) 

UPMC Division of Cardiology & Heart and Vascular Institute 

Pittsburgh, PA 

Randall C. Thompson, MD, FASNC 

Saint Luke’s Mid America Heart Institute 

University of Missouri-Kansas City 

Kansas City, MO 

David E. Winchester, MD, MS, FACP, FACC, FASNC 

Malcom Randall VAMC 

University of Florida College of Medicine 

Gainesville, FL 

Planners 

Jamieson Bourque, MD, MHS, FASNC (Course Director and Chair) 

Karthikeyan Ananthasubramaniam, MD, FASNC (Co-Chair) 

Victoria Anderson (ASNC staff) 

Wendy Passerell (ASNC staff) 

Reviewer 

Matthew E. Harinstein, MD, FASNC (Education Committee Oversight) 

Firas J. Al Badarin, MD (Education Committee Oversight) 

Disclosures 

As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), the American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s 2004 Standards for Commercial Support. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of relevant financial relationships with commercial companies and resolution of conflicts of interest.  The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy.  All planners, reviewers, and presenters involved with this activity were required to disclose any relevant financial relationships. 

The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interest through a peer-review process. 

The following planners, presenters, reviewers, and staff reported no financial relationships:

Gordon DePuey, MD, MASNC

Wendy Galbraith, PharmD, FAPhA, BCNP 

Matthew E. Harinstein, MD, FACC, FASE, FASNC 

Robert Hendel, MD, MASNC 

Wendy Passerell (ASNC Staff) 

Randall C. Thompson, MD, FASNC 

David E. Winchester, MD, MS, FACP 

The following planners, presenters, reviewers, and staff reported financial relationships: 

Firas J. Al Badarin, MD: Advisory Board: Pfizer 

Karthik Ananthasubramaniam, MD, FASNC: Advisory Board: Alnylam Pharmaceuticals. 

Research grants: Alnylam Pharmaceuticals, Astellas Pharma U.S. Inc., Lantheus Medical Imaging, MyoKardia Inc. 

Victoria Anderson (ASNC staff): Stock Interest, Abbott Labs and AbbVie Inc. 

Jamieson Bourque, MD, MHS, FASNC: Consultant fee: Pfizer, GE Healthcare; Stock Interest: Locus Health 

James A. Case, PhD, MASNC: Consultant fee: General Electric; Research Grants: Bracco Diagnostics, General Electric, Jubilant Imaging; Intellectual Property Rights: Cardiovascular Imaging Technologies; Stock Interest: CVIT; Royalty: Cardiovascular Imaging Technologies, LLC; Salaried Employee or Owner: Cardiovascular Imaging Technologies, LLC 

Panithaya Chareonthaitawee, MD, FACC, FAHA: Consultant fee: Bioclinica, GE Healthcare, MedTrace; Royalty: UpToDate®

David Cooke, MSEE: Royalty: Syntermed, Inc. (Sales of Emory Cardiac Toolbox Software); Salaried Employee or Owner: Part-time employee of Syntermed, Inc.

Marcelo F. Di Carli, MD, MASNC: Research Grants: Gilead Sciences, Spectrum Dynamics; Funding from NHLB 

Mark C. Hyun, CNMT, NCT, RT(N)(R)(CT), FASNC: Speakers Bureau: Astellas 

Saurabh Malhotra, MD, MPH, FACC, FASNC: Consultant fee: Alnylam; Speakers Bureau: Alnylam, Pfizer; Research Grant: Pfizer, Inc., Women’s Interagency HIV Study (WIHS); Advisory Board: Alnylam; Application Reviewer: Intersocietal Accreditation Commission (IAC) 

Ronald G. Schwartz, MD, MASNC: Speakers Bureau: Astellas 

Prem Soman, MD, PhD, MASNC, FACC, FRCP (UK): Advisory Board: Alnylam, Eidos, Ionis, Pfizer; Research Grant: Astellas Pharma, Pfizer (grant funding to University of Pittsburgh) 

The American Society of Nuclear Cardiology reserves the right to modify faculty and topics as needed. 

Off-Label Use 

Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the U.S. Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented.  Presenters are required to disclose to the learners, if there is any off-label usage within the presentation. 

Acknowledgement of Commercial Support 

This activity has not received any commercial support. 

Method of Participation and CME Certificates 

This product offers up to 26.5 AMA PRA Category 1 creditsTM and 26.5 ABIM Part II medical knowledge MOC points based on the number of hours you spend watching presentations and taking the post-test questions. You may re-enter the product as many times as you wish, but you can claim CME credit and MOC points only once.  

To receive CME credit for this product, you must: 

  1. Purchase the product. 
  2. Read the CME Information available when you first enter the player or by clicking the CME Info link in the top right corner. 
  3. View the session(s) of your choosing. 
  4. After you have completed viewing all sessions for which you intend to claim credit, click the Test link in the top right corner to begin the post-test, which is required to claim credit. 
  5. Complete the post-test. You must score 80% to earn credit. You have unlimited attempts to retake the post-test.  
  6. Complete the meeting evaluation. 
  7. Enter the number of credits you wish to claim (up to a maximum of 26.5 CME credits). Credits claimed should reflect the total number of hours you spent reviewing the CME information, watching sessions, and taking the post-test. (*If you already claimed credit for attending the virtual live Nuclear Cardiology Board Exam Prep Course, you may not claim credit for the same sessions on Nuclear Cardiology Board Prep OnDemand).   
  8. Generate and print your CME certificate. 

Estimated time for completion of activity is 26.5 hours. 

Learner’s Bill of Rights 

The American Society of Nuclear Cardiology (ASNC) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill, or performance. As part of the ASNC’s duty to you as a learner, you have the right to expect that your continuing medical education experience with ASNC includes the following: 

Content that: 

  • promotes improvements or quality in healthcare; 
  • is valid, reliable, and accurate; 
  • offers balanced presentations that are free of commercial bias for or against a product or service; 
  • is vetted through a process that resolves any conflicts of interests of planners, teachers, or authors;  
  • is driven and based on learning needs, not commercial interests; 
  • addresses the stated objectives or purpose; and 
  • is evaluated for its effectiveness in meeting the identified educational need. 

A learning environment that: 

  • supports the learners’ ability to meet their individual needs; 
  • respects and attends to any special needs of the learners; 
  • respects the diversity of groups of learners; and 
  • is free of promotional, commercial, and/or sales activities. 

Disclosure of: 

  • relevant financial relationships planners, teachers, and authors have with commercial interests related to the content of the activity; and 
  • commercial support (funding or in-kind resources) of the activity. 

Participants are asked to evaluate the objectivity of each presentation and to identify any perceived commercial bias. 

Medium or Combination of Medium Used:   

Nuclear Cardiology Board Prep OnDemand is available online on most mobile devices, including smartphones and tablets.    

Hardware/Software Requirements: For the most current list of system requirements, please visit http://asnc.ondemand.org/. 

Provider Contact Information: 

For Nuclear Cardiology Board Prep OnDemand Customer Support: 

[email protected] or (818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only) 

ASNC Contact Information: 

American Society of Nuclear Cardiology 
9302 Lee Highway, Suite 1210 
Fairfax, Virginia 22031 
Phone: 703-459-2555 
[email protected] 

Privacy Policy 

This website is provided by Learner’s Digest International LLC.  By using this website you consent to the use of your Personal Data (Defined Below) as described in this Privacy Policy (‘Policy’). The Privacy Policy can be found at www.audio-digest.org/privacy and may be updated at any time. 

 

ASNC Nuclear Cardiology Board Exam Preparation Course OnDemand 2020 is a digital library of 21.75 hours of educational content presented at the 2020 October 17–18 Nuclear Cardiology Virtual Board Examination Prep Meeting. 

Nuclear Cardiology Board Prep On Demand features: 

  • Online access to presenters’ slides with synchronized audio 
  • Searchable slide content 
  • Ability to earn up to 21.75 AMA PRA Category 1 Credits™ and 21.75 Maintenance of Certification (MOC) points 
  • PC and MAC compatible 
  • Mobile version for most smartphone and tablet devices 
  • MP3 downloads

Overall Goal 

The overall goal of this activity is to increase physician competence in nuclear cardiology by providing a comprehensive review, including the most up-to-date information, developments, treatment protocols, methodology, and best test for the right patient at the right time to optimize patient outcomes in their nuclear cardiology practice. 

Needs Statement 

Radionuclide-based cardiac imaging studies, including myocardial perfusion imaging (MPI), play an important role in the diagnosis and management of patients with suspected or known heart disease. Today more than 5000 laboratories are performing an estimated 8 million myocardial perfusion studies, of which 58% use pharmacological stress agents, either alone or with exercise.* A large body of scientific evidence exists on the clinical value of MPI, based on studies performed on many thousands of patients. These studies are highly sensitive and specific for the diagnosis, prognosis, and treatment response of coronary artery disease, as well as for selection of patients who may benefit from other types of intervention, including revascularization and device therapy. The value and justification of MPI for risk assessment is based on large observational outcome studies. As a result of the recognized clinical value and cost effectiveness of these studies, they have been incorporated into many ACC/American Heart Association (AHA)/ASNC clinical management guidelines.  

Nuclear cardiology is an evolving field with continuing advances in software, instrumentation, and radiopharmaceuticals to provide high quality, clinically relevant information for patient care. These advances require those involved in providing nuclear cardiology studies to be updated continuously, to ensure the procedures are used appropriately and safely, and to assure recent clinical and technological advances are incorporated in a timely manner to continually improve the image quality and interpretation to provide the best clinical care.   

*Dicardiology.com. IMV market report. Posted December 26, 2013. 

Target Audience 

This course is designed for cardiologists, nuclear medicine physicians, and radiologists preparing for the certification or recertification exam in nuclear cardiology.  

Learning Objectives 

The primary objectives of the course are to enable participants to achieve the following: 

  • Appraise knowledge of physics and instrumentation associated with nuclear imaging 
  • Explain image acquisition and processing, including artifacts 
  • Describe risk stratification 
  • Integrate radiation safety standards into professional practice 
  • Discuss the use of nuclear imaging in assessment viability, amyloidosis 
  • Understand basics of PET imaging for perfusion viability and sarcoidosis 
  • Interpret perfusion images, including SPECT, PET, and ventricular function imaging 
  • Utilize perfusion imaging in the assessment, diagnosis, and response to therapy in CAD patients and special populations 
  • Understand the basics on interpretation of non-cardiac findings on SPECT/PET CT

Important Dates: 

Date of Release:October 19, 2020 

Date of Last Review:October 19, 2020 

Date of Expiration:October 18, 2021 

Please note that credit will only be available through the term of approval noted above.  

Accreditation Statement 
Continuing Medical Education Credit 

The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Designation Statement 

The American Society of Nuclear Cardiology designates this enduring material for a maximum of 21.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Requirements for successful completion and awarding of credit are as follows: participation in sessions offering credit in their entirety and successful completion of the post test and evaluation tool.   

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the CME post-test and evaluation component, enables the participant to earn up to 21.75 medical knowledge Maintenance of Certification (MOC) points in the American Board of Internal Medicine (ABIM) MOC program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

To receive MOC points for participating in the Board Prep Course, you must be a diplomate of the American Board of Internal Medicine, and you must have an ABIM account. If you have not yet established an online account, you will need to visit http://www.abim.org, or contact ABIM by phone: 1-800-441-ABIM; Mon–Fri 8:30 am–8:00 pm ET, Sat 9:00 am–12:00 pm ET.  

Please note, upon satisfactory completion of your Board Prep Course, passing the CME post-test, and completing the evaluation form, you will be prompted to enter your ABIM ID and DOB so your MOC points can be transferred to the ABIM. Please note this data will transfer at the end of every month into your ABIM record. 

*Please Note: If you already claimed credit for attending the virtual live Nuclear Cardiology Board Exam Prep meeting, you may not claim credit for watching the same sessions on Nuclear Cardiology Board Prep OnDemand.   

While offering the CME credits noted above, this program is not intended to provide extensive training or certification in the field. 

Program Chairs & Faculty 

Karthikeyan Ananthasubramaniam, MD, FASNC 

Program Chair
Henry Ford Hospital 

Detroit, MI 

Jamieson Bourque, MD, MHS, FASNC 

University of Virginia Health System 

Charlottesville, VA 

James A. Case, PhD, MASNC 

Cardiovascular Imaging Technologies 

Kansas City, MO 

Panithaya Chareonthaitawee, MD, FACC, FAHA 

Mayo Clinic College of Medicine 

Rochester, MN 

 David Cooke, MSEE

Emory University School of Medicine 

Atlanta, GA 

Gordon DePuey, MD, MASNC

Mount Sinai Morningside Hospital 

New York, NY 

Andrew C. Homb, MD 

Mayo Clinic College of Medicine 

Rochester, MN 

Robert Pagnanelli, BSRT(R)(N), CNMT, NCT, FASNC 

Duke Regional Hospital 

Durham, NC 

Rupa M. Sanghani, MD, FASNC 

Rush University Medical Center 

Chicago, IL 

Prem Soman, MD, PhD, MASNC, FACC, FRCP (UK) 

UPMC Heart and Vascular Institute 

Pittsburgh, PA 

Raymond Taillefer, MD, FRCP, ABNM 

Hospital Du Haut–Richelieu 

Quebec, Canada 

Jason Tavel, PhD, DABR 

Astarita Associates, Inc. 

Smithtown, NY 

Planners 

Karthikeyan Ananthasubramaniam, MD, FASNC (Chair and Course Director) 

Victoria Anderson (ASNC staff) 

Wendy Passerell (ASNC staff) 

Reviewer 

Matthew E. Harinstein, MD, FACC, FASE, FASNC (Education Committee Oversight) 

Firas J. Al Badarin, MD (Education Committee Oversight) 

Disclosures 

As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), the American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s 2004 Standards for Commercial Support. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of relevant financial relationships with commercial companies and resolution of conflicts of interest.  The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy.  All planners, reviewers, and presenters involved with this activity were required to disclose any relevant financial relationships.  

The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interest through a peer–review process. 

The following planners, presenters, reviewers, and staff reported no financial relationships: 

Victoria Anderson (ASNC staff) 

Firas J. Al Badarin, MD

Gordon DePuey, MD, MASNC

Matthew E. Harinstein, MD, FACC, FASE, FASNC  

Andrew C. Homb, MD 

Wendy Passerell (ASNC Staff) 

Rupa M. Sanghani, MD, FASNC 

Raymond Taillefer, MD, FRCP, ABNM 

Jason Tavel, PhD, DABR 

The following planners, presenters, reviewers, and staff reported financial relationships: 

Victoria Anderson (ASNC staff): Stock Interest, Abbott Labs and AbbVie Inc. 

Karthik Ananthasubramaniam, MD, FASNC: Consultant fee: Astellas Pharma; Research grants: Astellas Pharma U.S. Inc., Lantheus Medical Imaging, MyoKardia Inc.; Speakers’ Bureau: Lantheus Medical Imaging  

Jamieson Bourque, MD, MHS, FASNC: Consultant fee: Pfizer, GE Healthcare; Stock Interest: Locus Health 

James A. Case, PhD, MASNC: Intellectual Property Rights: Cardiovascular Imaging Technologies; Consultant fee: General Electric; Research Grants: Jubilant Imaging, Bracco Diagnostics; Salaried Employee or Owner: Cardiovascular Imaging Technologies 

Panithaya Chareonthaitawee, MD, FACC, FAHA: Consultant fee: Bioclinica, GE Healthcare, MedTrace; Royalty: UpToDate®

David Cooke, MSEE: Royalty: Syntermed, Inc. (Sales of Emory Cardiac Toolbox Software); Salaried Employee or Owner: Part-time employee of Syntermed, Inc.

Robert Pagnanelli, BSRT(R)(N), CNMT, NCT, FASNC: Speakers’ Bureau: Astellas Pharma U.S. Inc.  

Prem Soman, MD, PhD, MASNC, FACC, FRCP (UK): Advisory Board: Alnylam, Ionis Pharmaceuticals, Pfizer; Research Grants: Astellas Pharma, Pfizer 

The American Society of Nuclear Cardiology reserves the right to modify faculty and topics as needed. 

Off–Label Use  

Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the U.S. Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented.  Presenters are required to disclose to the learners, if there is any off-label usage within the presentation. 

Acknowledgement of Commercial Support 

This activity has not received any commercial support. 

Method of Participation and CME Certificates 

This product offers up to 21.75 AMA PRA Category 1 creditsTM and 21.75 ABIM Part II medical knowledge MOC points based on the number of hours you spend watching presentations and taking the post-test questions. You may re-enter the product as many times as you wish, but you can claim CME credit and MOC points only once.  

To receive CME credit for this product, you must: 

  1. Purchase the product.  
  2. Read the CME Information available when you first enter the player or by clicking the CME Info link in the top right corner.
  3. View the session(s) of your choosing.
  4. After you have completed viewing all sessions for which you intend to claim credit, click the Test link in the top right corner to begin the post-test, which is required to claim credit.
  5. Complete the post-test. You must score 80% to earn credit. You have unlimited attempts to retake the post-test.  
  6. Complete the meeting evaluation.
  7. Enter the number of credits you wish to claim (up to a maximum of 21.75 credits). Credits claimed should reflect the total number of hours you spent reviewing the CME information, watching sessions, and taking the post-test. (*Please Note: If you already claimed credit for attending the virtual live Nuclear Cardiology Board Exam Prep Course, you may not claim credit for the same sessions on Nuclear Cardiology Board Prep OnDemand).  
  8. Generate and print your CME certificate.

Estimated time for completion of activity is 21.75 hours. 

Learner’s Bill of Rights 

The American Society of Nuclear Cardiology (ASNC) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill, or performance. As part of the ASNC’s duty to you as a learner, you have the right to expect that your continuing medical education experience with ASNC includes the following: 

Content that: 

  • promotes improvements or quality in healthcare; 
  • is valid, reliable, and accurate; 
  • offers balanced presentations that are free of commercial bias for or against a product or service; 
  • is vetted through a process that resolves any conflicts of interests of planners, teachers, or authors;  
  • is driven and based on learning needs, not commercial interests; 
  • addresses the stated objectives or purpose; and 
  • is evaluated for its effectiveness in meeting the identified educational need.

A learning environment that: 

  • supports the learners’ ability to meet their individual needs; 
  • respects and attends to any special needs of the learners; 
  • respects the diversity of groups of learners; and 
  • is free of promotional, commercial, and/or sales activities.

Disclosure of: 

  • relevant financial relationships planners, teachers, and authors have with commercial interests related to the content of the activity; and 
  • commercial support (funding or in-kind resources) of the activity.

Participants are asked to evaluate the objectivity of each presentation, and to identify any perceived commercial bias. 

Medium or Combination of Medium Used:   

Nuclear Cardiology Board Prep OnDemand is available online on most mobile devices, including smartphones and tablets.    

Hardware/Software Requirements: for the most current list of system requirements, please visit http://asnc.ondemand.org/. 

Provider Contact Information: 

For Nuclear Cardiology Board Prep OnDemand Customer Support:  

[email protected] or (818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only) 

ASNC Contact Information: 

American Society of Nuclear Cardiology
9302 Lee Highway, Suite 1210
Fairfax, Virginia 22031
Phone: 703-459-2555
[email protected] 

Privacy Policy 

This website is provided by Wolters Kluwer N.V. and/or its subsidiaries. By using this Website you consent to the use of your Personal Data as described in our Privacy Policy (“Policy”).

The Privacy Policy can be found at www.audio-digest.org/privacy and may be updated at any time.

Sync Across All Devices

Earn Credits with Online Testing 

Download PDFs and MP3 Files

ASNC Nuclear Cardiology Board Prep OnDemand

Add Your Heading Text Here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Click here
Close Menu